Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Lexagene Holdings Inc > PP at .85 Canadian Just Around The Corner
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(159)
•••
Comment by TanzaniteMotherLodeon Aug 11, 2020 8:58am
79 Views
Post# 31391668

RE:PP at .85 Canadian Just Around The Corner

RE:PP at .85 Canadian Just Around The CornerHe's too busy complaining to make wise trades.  I think you're right about the pp


CashFerBugs wrote:
Letsdoit you have to get in when management gives the market maker shares to play. Remember in spring when over 3 million shares were traded 0.45 to 0.55. It was planned to run this back then. I got in and got out. I was watching the mysterious volumes and detected a cross going on. My broker friend who scolded me and told me to be careful as he was in this in 2018. He figures money is heading offshore via maket maker via BMO when he held till 2019 especially after last PP (200k dumps). LOL even Jack on one of recent interviews called it a box at the hospital.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities